Onto Innovation vs Teradyne
Add, change or remove companies; up to four.
KIRA’s take AI analyst
I put Onto Innovation and Teradyne side by side, using each one’s latest annual report. Here is what stands out:
- Teradyne is the larger business, with $3.2B of revenue in fiscal 2025 against $1.0B for Onto Innovation, about 3.2 times as much.
- Teradyne grew revenue faster (13.1%, against 1.8%).
- Teradyne kept more of each dollar of sales as operating profit (20.4% operating margin, against 13.2%).
- Onto Innovation turned more of its sales into free cash flow (29.8% FCF margin, against 14.1%).
- Teradyne earned a higher return on the capital invested in it (23.0%, against 8.8%).
Who comes out ahead
Of the 11 measures where higher (or lower) is clearly better, how many each company leads.
Onto Innovation
ONTO
3/11
5-year growthFCF marginNet debt / EBITDA
Teradyne
TER
8/11
Revenue growthGross marginOperating marginNet marginReturn on capitalReturn on equityPiotroski F-scoreShare count change
Side by side
Best in the row
| Latest fiscal year | ONTO FY25 | TER FY25 |
|---|---|---|
| Size | ||
| Market cap | $9.9B | $49.3B |
| Revenue | $1.0B | $3.2B |
| Free cash flow | $300M | $450M |
| Net income | $137M | $554M |
| Growth | ||
| Revenue growth | 1.8% | 13.1% |
| 5-year growth | 12.6% | 0.4% |
| Share count change | −0.8% | −2.2% |
| Profitability | ||
| Gross margin | 49.7% | 58.2% |
| Operating margin | 13.2% | 20.4% |
| Net margin | 13.6% | 17.4% |
| FCF margin | 29.8% | 14.1% |
| Return on capital | 8.8% | 23.0% |
| Return on equity | 6.8% | 19.7% |
| Balance sheet | ||
| Net debt | −$640M | −$93.8M |
| Net debt / EBITDA | −3.3x | −0.1x |
| Dividends and buybacks | $75.0M | $778M |
| Valuation & quality | ||
| P/E | 74.7x | — |
| Piotroski F-score | 4 | 5 |
Ten years
Revenue
Operating margin
Free cash flow
Return on capital
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.

